Isomerase, a leader in contract fermentation process development, is proud to announce the integration of its process innovation capabilities into its end-to-end platform for protein discovery and ...

Isomerase has today announced the release of its Isochassis platform, a comprehensive collection of proprietary engineered microbial hosts designed to meet industrial recombinant protein and biologics ...

Absorption of a light particle by an opsin-pigment causes photoisomerization of its retinaldehyde chromophore. Restoration of light sensitivity to the resulting apo-opsin requires chemical ...

This paper demonstrates a previously undescribed defect of a glycolytic enzyme, triosephosphate isomerase, in the erythrocytes and leukocytes of a patient with congenital hemolytic anemia. The carrier ...

Swedish drug developer NeuroVive Pharmaceutical is cozying up to R&D partner Isomerase Therapeutics, buying a stake in the company as the two move together on a CNS project. Under the agreement, ...

NeuroVive Pharmaceutical AB (publ)(STO:NVP), the mitochondrial medicine company, announces the partial acquisition of British company Isomerase Therapeutics ("Isomerase") with the overall goal to ...